Science and Therapeutic Area
We have two monoclonal antibody production bases in China, located in Wujiang, Suzhou and Lingang, Shanghai.
We always prioritize the quality management of products by establishing comprehensive standards, processes and specifications to guarantee the production of high-quality products.
The 1st monoclonal antibody factory in China obtained GMP Certificate based on production platform with single-use system
4,500L commercial capability
Construction completed in 2016
Responsible for investigational and commercial products‘ manufacturing
Construction in compliance with CGMP standards. Aiming at creating an intelligent benchmark in monoclonal antibody biopharmaceutical industry
Phase I project fermentation capability reaches 42,000L
Obtained GMP Certificate in May, 2022. Responsible for investigational and commercial products‘ manufacturing